Showing 1 - 8 results of 8 for search '"GW Pharmaceuticals"', query time: 0.18s Refine Results
  1. 1
    Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain

    Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain by Lisa A. Lione, Amy Fisher

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II

    Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II by Lisa A. Lione, Amy Fisher

    Published 2024-06-01
    Get full text
    Article
  3. 3
    National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management

    National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management by Rhys H. Thomas, Jacob Brolly

    Published 2020-06-01
    “…For epilepsy, cannabidiol (CBD) (Epidyolex®, GW Pharmaceuticals, Cambridge, UK) is recommended in conjunction with clobazam for treating seizures associated with Lennox–Gastaut syndrome and Dravet syndrome in patients aged ≥2 years. …”
    Get full text
    Article
  4. 4
    The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products

    The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products by Emilio Russo, Paula Martinez Agredano, Peter Flachenecker, Charlotte Lawthom, Duncan Munro, Chandni Hindocha, Makarand Bagul, Eugen Trinka

    Published 2024-07-01
    Get full text
    Article
  5. 5
    Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex

    Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex by S. Amin, B. Ruban-Fell, I. Newell, J. Evans, K. Vyas, C. Nortvedt, R. F. Chin

    Published 2024-02-01
    Get full text
    Article
  6. 6
    Nordic treatment guidelines for rare epileptic conditions: A literature review

    Nordic treatment guidelines for rare epileptic conditions: A literature review by Kishan Vyas, Hannah Luedke, Benjamin Ruban‐Fell

    Published 2022-07-01
    Get full text
    Article
  7. 7
    Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles

    Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles by Uchini S. Kosgodage, Paul Matewele, Brigitte Awamaria, Igor Kraev, Purva Warde, Giulia Mastroianni, Alistair V. Nunn, Geoffrey W. Guy, Jimmy D. Bell, Jameel M. Inal, Sigrun Lange

    Published 2019-09-01
    Get full text
    Article
  8. 8
    Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

    Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection by Gabriella Captur, James C. Moon, Constantin-Cristian Topriceanu, George Joy, Leo Swadling, Jenny Hallqvist, Ivan Doykov, Nina Patel, Justyna Spiewak, Tomas Baldwin, Matt Hamblin, Katia Menacho, Marianna Fontana, Thomas A. Treibel, Charlotte Manisty, Ben O'Brien, Joseph M. Gibbons, Corrina Pade, Tim Brooks, Daniel M. Altmann, Rosemary J. Boyton, Áine McKnight, Mala K. Maini, Mahdad Noursadeghi, Kevin Mills, Wendy E. Heywood

    Published 2022-11-01
    “…Funding information: The COVIDsortium is supported by funding donated by individuals, charitable Trusts, and corporations including Goldman Sachs, Citadel and Citadel Securities, The Guy Foundation, GW Pharmaceuticals, Kusuma Trust, and Jagclif Charitable Trust, and enabled by Barts Charity with support from University College London Hospitals (UCLH) Charity. …”
    Get full text
    Article

Search Tools: